<DOC>
	<DOCNO>NCT01589822</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness EVICEL® Fibrin Sealant ( Human ) use adjunct gastrointestinal ( GI ) surgery .</brief_summary>
	<brief_title>The EVICEL® Gastrointestinal Study</brief_title>
	<detailed_description>This single blind , randomize , multi-center control study evaluate safety effectiveness EVICEL® use adjunct gastrointestinal ( GI ) surgery .</detailed_description>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subjects undergoing primary elective GI surgery Subjects ≥ 18 year age willing participate study provide write informed consent prior studyrelated procedure Avastin use within 30 day prior surgery ; Known hypersensitivity human blood product component investigational product ; Female subject pregnant nursing ; Exposure another investigational drug device clinical trial within 30 day prior surgery planned/intended 90 day follow period surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>